HIGHLIGHTS
- who: Xun Qiu et al. from the Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People`s Hospital, Zhejiang University School of Medicine, Hangzhou, China have published the research work: P-21 Activated Kinases in Liver Disorders, in the Journal: Cancers 2023, 551 of 11/01/2023
- what: In this review the authors have summarized the currently available studies about the role of PAKs in liver disorders and the mechanisms involved and further explored the potential therapeutic application of PAK inhibitors in liver disorders with the aim to provide a comprehensive overview on current progress and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.